Summary

The Commission Nationale de l'Informatique et des Libertés (CNIL), France's data protection watchdog, has published a report summarizing data breaches over the last five years.

A Report Focusing on Crucial Elements of Data Breaches

Through a collection of graphs and diagrams, the CNIL addresses several key aspects of data breaches, including:

  • The number of reported breaches
  • Distribution by sector and type of activity
  • Origins of data breaches (external, internal, other)
  • Data breaches by geographical area
  • Time taken to detect a breach

This report offers valuable insights for businesses, providing a broad overview of potential vulnerabilities and areas for enhancement.

Full Report

Seamus Larroque

CDPO / CPIM / ISO 27005 Certified

Home

Discover our latest articles

View All Blog Posts
June 11, 2026
Events
Data Governance
Data Privacy Enforcement
Health Data Warehouse

Vendor GDPR in Clinical Trials: What the IQVIA CNIL Ruling Changes for Sponsors and Healthtech Companies

On 26 May 2026 the CNIL fined IQVIA Operations France EUR 5 million for failures in its two authorised health data warehouses, LRX and EMR. The decision exposes weaknesses in CRO data protection practice that have direct consequences for every pharmaceutical sponsor relying on a CRO to process patient, prescription or trial data. This article unpacks the four areas of failure, explains why pseudonymisation no longer offers the cover many sponsors assume, and sets out a practical oversight checklist for sponsor data controllers.

February 9, 2026
AI
Biotech & Healthtech
Regulations & Guidelines
Healthcare

EU AI Act for Healthcare: What Life Sciences Companies Need to Know before August 2026

EU AI Act 2026 healthcare enforcement requires immediate compliance to avoid penalties.

February 2, 2026
Healthtech
US Privacy Law
USA

Navigating US Regulatory Requirements for AI-Powered Medical Devices: A Comprehensive Guide to FDA, HIPAA, and IRB Compliance

US AI medical device compliance requires navigating FDA, HIPAA, IRBs, and consent waivers strategically.

FAQs

Our frequently questions

No items found.